TERF2 and neoplasm: Interestingly, being TRF2 expression correlated with the aggressive phenotype of different tumor histotypes, included TNBC, it is reasonable to suppose that reduced tumor dissemination following the treatment with taxanes is attributable to selective killing of the fraction of tumor cells expressing high TRF2 levels.